Introduction {#S1}
============

The "difficult sequence" concept has been introduced in the 80's and was given distinction by Kent and co-workers for peptides that form strong inter- or intra molecular, non-covalent interactions which form insoluble peptide aggregates. "Difficult sequences" are peptide sequences that contain high number of amino acids possessing hydrophobic side chains, so-called β-branched amino acids, including leucine, valine, phenylalanine or isoleucine. Additionally, glycine is known to induce β-sheet packing in combination with afore mentioned amino acids ([@B104]). These sequences tend to form β-sheet or α-helical structures within the molecule and therefore they have high aggregation potential and low solubility in aqueous or organic solvents. This results in a generally difficult handling, synthesis and purification.

One should consider that the chemical production of "difficult sequences" is composed of several key steps, which include SPPS, analytical characterization, purification, fragment ligation and if needed post ligation steps ([Figure 1](#F1){ref-type="fig"}). Each mentioned step is challenging because of the high probability of "difficult sequences" to aggregate and precipitate in conventional solvents ([Figure 2](#F2){ref-type="fig"}). Consequently, solubility of "difficult" peptides and proteins is needed at every key step of their production route. Last decades, researchers developed various methods to achieve this major goal. However, when screening through the literature, unfortunately no unique protocol is available for the synthesis of highly hydrophobic "difficult" peptides and proteins. Nowadays, for every new intended synthesis, special optimization of SPPS, NCL and follow-up protocols are still required.

![Schematic way for chemical production of highly hydrophobic peptides with highlighted key steps requiring solubility.](fbioe-08-00162-g001){#F1}

![Aggregation of highly hydrophobic peptides as a challenging behavior for chemical synthesis.](fbioe-08-00162-g002){#F2}

In this review we highlight, summarize and evaluate the possibilities for synthetic production of "difficult sequences" by SPPS, native chemical ligation (NCL) and follow-up protocols.

Success Reports in Synthesis of Transmembrane Proteins {#S2}
======================================================

Focusing on the class of heavy synthetically accessible proteins such as membrane proteins and considering their structural and functional divergence we will summarize in following efforts undertaken for their synthetic production. It is worth to mention that membrane proteins are encoded by 20--30% of the human genome ([@B140]; [@B109]; [@B75]; [@B85]; [@B79]). Thereupon, it is not surprising, that because of this relatively high abundance, membrane proteins are of great interest as drug targets. This can be seen in the number of available drugs that target these structures. Around 60% of all FDA-approved drugs address these structures, e.g., GPCRs or ion channels ([@B151]) and the interest in therapeutic applications or for the design of nanopore-based bio-inspired sensors is rising. Surprisingly, until 2003 only about 60 high-resolution structures of transmembrane proteins were available despite their great importance for the cell function and drug design ([@B85]). With the Nobel prize in 2017, awarded to J. Dubochet, J. Frank, and R. Henderson on their outstanding work in cryo-electron-microscopy, this situation changed rapidly ([@B26]; [@B3]). High profile structures, dynamics and structural studies of various membrane proteins are now available, including works on calcium-selective ion channels ([@B152]), voltage-gated potassium channels ([@B118]; [@B119]) and a membrane-embedded monomeric yeast ATP synthase ([@B123]).

However, there is still a challenge to provide access to enough material to determine structures and functions of membrane proteins. Two major ways are possible either to chemically synthesize or recombinantly express membrane proteins.

Four major problems in expression of these structures led to the development of strategies using chemical synthesis: (1) protocols for the recombinant expression of hydrophilic structures are often not applicable to hydrophobic proteins, (2) over-expression of membrane proteins usually leads to membrane disruption and thus cell toxicity, (3) extraction and purification are not trivial, and (4) limitations in incorporation of post-translational modifications/isotopic labels ([@B116]).

Trying to overcome these problems, a bridge between biology and chemistry was required, resulting in an outstanding cooperation. A great advantage of chemical synthesis displays the possibility to custom design of the desired sequence. As soon as the successful synthetic protocol is elaborated, the integration of unnatural amino acids, mutations at arbitrary positions, post-translational modifications (PTMs) and site-specific labels for e.g., solid-state/solution NMR spectroscopy or fluorescence microscopy experiments is readily possible ([@B111]). Furthermore, product in the multi-milligram range can be obtained making numerous analytical experiments possible, leading to a better structural and functional understanding. The establishment of a successful chemical synthesis strategy, though, faces some challenges.

Due to the challenges in synthesis of "difficult sequences" especially membrane proteins or their functional parts, only few manuscripts report successful examples and are summarized in [Table 1](#T1){ref-type="table"} identifying special features of the synthetic strategy.

###### 

Overview of successful chemical (semi-)synthesis protocols for transmembrane proteins (extended from [@B116]).

  **Name**                                                               **Protein length**   **Protocol, SPPS**                                                **SPPS**                                                                            **Facilitating NCL**           **Special features**                                                                                   **References**
  ---------------------------------------------------------------------- -------------------- ----------------------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------ ------------------------------------------------------------------------------------------------------ ----------------
  **NS4A**, cofactor protein of serine protease from Hepatitis C virus   1--66                Fragment 1: Boc-based Fragment 2: Fmoc-based                      Fragment 1: tri-lysine solubilizing tag Fragment 2: tetra-lysine solubilizing tag   β-octyl-glucoside              One of the first described synthesis routes                                                            [@B9]
  **BM2** proton channel, influenza A                                    1--97                Both fragments: Boc-based                                                                                                                             30% TFE                                                                                                                               [@B73]
  Potassium Channel **KcsA**                                             1--125               Fragment 1-73 recombinant expression Fragment 74-125: Boc-based                                                                                       50% TFE, 1% SDS                Thioester Fragment 1-73, Great difficulties in solubilizing synthesized fragment, T74C mutation        [@B137]
  Mechano-selective ion channels: **Ec-MscL** and **Tb-MscL**            1--136               All fragments: Boc-based                                                                                                                              Dodecyl-phospho-choline, DPC   Ec-MscL: Q56C and N103C mutations Tb-MscL: E102C and S52C mutations, Acm protection group              [@B23]
  Diacylglycerol Kinase from E. Coli, **DAGK**                           1--121               Three fragments: Boc-based                                        Polyethylene glycol-polyamide (PPO) tag and hexa-arginine tag                       DPC or OG                      Several solubilizing tags were tested                                                                  [@B78]
  Inward rectifier K+ channel protein **Kir 5.1**                        64--179              Four fragments: Fmoc-based                                        Fragment 3: tetra-arginine tag                                                      DPC                            Hydrazides for NCL, usage of pseudoprolines                                                            [@B161]
  Hepatitis C Virus cation-specific ion channel **p7**                   1--63                Both fragments: Fmoc-based                                        Both fragments: tetra-arginine tag                                                                                 Hydrazides for NCL, removable backbone modifications (RBM) consisting of polyargininge-tagged groups   [@B160]
  Ser64-phosphorylated **BM2** proton channel, influenza A virus         1--97                Both fragments: Fmoc-based                                        Solubilizing unit Arg4 (RBM)                                                                                       Hydrazide mediated NCL, Arg4 tag removed at end (TFA)                                                  [@B127]
  **BM2** proton channel, influenza A virus                              1--51                Both fragments: Fmoc-based                                        Various solubilizing tags (ADO, ADO2, ADO-Lys5)                                     TFE or HFIP (2:1)              Oxo-ester for NCL                                                                                      [@B7]
  Copper storage protein 1 **CSP-1**                                     1--122               Three fragments: Fmoc-based                                       Three fragments: Phacm solubilizing tag                                                                            Phacm temporary solubilizing tag, selective palladium-mediated deprotection of Thz                     [@B56]
  Interferon-induced transmembrane protein 3 (**IFITM3**)                1--133               Fmoc-based                                                        Oligo-arginine (Arg7)                                                               95:5 NMP:H2O                   KAHA ligation\*                                                                                        [@B42]

\*See outlook section for more information.

Evaluating the synthetic strategies, a definite shift from Boc-based synthesis to the less toxic Fmoc-based protocols from 2010 is visible which can be connected to the increasing availability of novel NCL strategies. An advancement of the hydrazide mediated NCL is noticeable with NCL yields of 39% ([@B160]; [@B127]). However, this method is hampered by impossible incorporation of removable C-terminal solubilizing tag to the hydrazide moiety. Lately, [@B7] presents an oxo-ester mediated NCL with almost quantitative NCL yields introducing an interesting prospect by attaching removable solubilizing tag to the oxo-ester. This strategy benefits from the easier handling of highly hydrophobic thioester-forming peptide due to its solubility while purification and analysis prior to NCL. Moreover, no additional steps are required to remove the solubility tag from the peptide sequence, it is automatically removed at NCL conditions. Another example is the use of removable backbone modifications which remain stable throughout NCL, facilitating the reaction, and are readily cleaved off afterward using TFA. Additionally, as seen in the table ([Table 1](#T1){ref-type="table"}), a preference for arginine-based solubilizing tags can be noticed. A brilliant example of using an arginine tag \[phenylacetamidomethyl (Phacm) attached to cysteine\] and selective orthogonal removal of the Cys masking group 1,3-thiazolidine-4-carboxylic acid (Thz) without affecting this tag was demonstrated by [@B56]. Moreover, most of the presented synthetic strategies include addition of organic solvents such as TFE ([@B73]; [@B137]; [@B7]) or surfactants like OG and DPC ([@B9]; [@B23]; [@B78]; [@B161]) to the ligation solution. Finally, Tang et al. presented a synthesis and ligation route toward BM2 that was published as a protocol, establishing a basis for generation of general approach.

The successful synthesis of highly hydrophobic sequences represents the feasibility of the strategies developed during last decades. However, divergence of the methods does not give a standard recipe for scientists on which method is the most applicable for the chemical production of novel sequences. Therefore, we designed a "yes-no" diagram which is intended to facilitate decisions at each production step and in following chapters we highlight mentioned methods in more detail ([Figure 3](#F3){ref-type="fig"}).

!["Yes-no" diagram for making decisions in the process of "difficult sequences" chemical production.](fbioe-08-00162-g003){#F3}

Solid Phase Peptide Synthesis and Native Chemical Ligation of "Difficult Sequences" {#S3}
===================================================================================

The introduction of solid phase peptide synthesis (SPPS) in 1963 by Merrifield revolutionized the former state-of-the-art liquid phase strategies and made synthesis of peptides and proteins easier, more efficient and accessible ([@B86], [@B87]). Within the next years, this strategy was continuously improved but it was only in 1970 that Carpino and Han transformed the working scheme by introduction of Fmoc-based strategy ([@B18]) making this the more advantageous and less toxic version of SPPS with respect to usage of hazardous hydrofluoric acid (HF) ([@B101]; [@B55]). This improvement in reaction conditions led to a rise in prosperous synthesis of peptides following the Fmoc-protocol, making automated synthesis applicable. However, peptide chains of "difficult sequences" exhibiting over 50--60 amino acids remain a challenge even when applying automated peptide synthesis protocols ([@B72]; [@B117]; [@B101]; [@B8]). Microwave assistance is usually advantageous to improve the yield of the final peptide, which however reaches its limits while synthesizing "difficult sequences" ([@B36]; [@B104]).

The last decades have witnessed an unprecedented progress in chemical peptide synthesis, however there were still sequences which were difficult or even impossible to synthesize by standard SPPS belonging to class of "difficult sequences," i.e., amylin ([@B25]; [@B45]), Aβ(1-42) ([@B4]; [@B65]), and BM2(1--51) ([@B7]). With respect to SPPS "difficult sequences" are defined as peptides that are poorly solvated while attached to the solid support thus preventing complete deprotection and coupling steps ([@B131]). This "on resin aggregation" is often associated with sequences that contain β-sheets or α-helices which are mostly represented in membrane-associated peptides/proteins. The type and loading capacity of the resin support has a tremendous influence on the quality of the crude peptide. For hydrophobic peptides non-polar resins such as polystyrene proved to result in peptide products with high quality, yield and purity compared to peptides synthesized on polar resin such as polydimethylacrylamide ([@B131]). This finding can be explained by the minor aggregation potential of hydrophobic amino acids sequences on polar resins. For the Boc-based SPPS protocol one of the first strategies which is used to optimize involves the acetylation of the imino-group of histidine and was introduced in 1966 by Weygand, subsequently being used by others ([@B144]). [@B99] investigated the impact of the solvent during coupling. Using DMF, they received a yield of 4% when synthesizing a hydrophobic transmembrane 34-residue peptide fragment of the rat bradykinin receptor. By changing the solvent to 80% NMP/DMSO increased coupling yields (12%) were observed due to improved swelling of the benzhydrylamine (BHAR) resin (loading: 0.34 mmol/g), while testing the Fmoc-based SPPS, no product was obtained.

In general, Boc-based SPPS is known to show better results for the synthesis of "difficult sequences" compared to the Fmoc-based strategy ([@B115]; [@B32]). This is, on one hand, ascribable to TFA, which selectively dissolves the protected peptide chain during SPPS and disrupts formations of secondary structures ([@B115]). On the other hand, optimizations of Boc-based SPPS protocols using *in situ* neutralization protocols, favors synthesis of difficult sequences as well. Treatment with TFA leads to the formation of α-ammonium species that needs to be neutralized prior to coupling, but when neutralized, leads to aggregation. Using an *in situ* protocol, a high concentration of activated amino acid in a polar solvent containing DIEA is added directly, thus minimizing aggregation ([@B2]; [@B115]). One of the limitations using Boc-based SPPS is caused by the continuous use of strong acid during and cleavage from the resin with HF though. Therefore, Boc-based SPPS is not suitable for backbone modifications designed for Fmoc-based SPPS. Nevertheless, Johnson and Kent introduced a photolytically cleavable 4-methoxy-2-nitrobenzyl (2-Nb) and 4-methoxy-2-nitrobenzyl (4-OMe-2-Nb) backbone amide protection groups, illustrated on a model peptide MG(X)GFL (X = 2-Nb or 4-OMe-2-Nb) that can be introduced for the synthesis of "difficult sequences" using the Boc-based protocol ([@B60]).

With the rising interest, especially regarding therapeutic and pharmaceutical research, a way to chemically synthesize longer peptides was needed since proteins feature 250 amino acids at an average ([@B72]; [@B70]). To generate an amide bond in solution one must go back to 1953, when [@B145] made use on an intramolecular acyl shift for peptide bond formation. This method was adapted and intensively studied by Kemp and co-workers, laying the foundation of todays' ligation strategies to fuse two or more peptide fragment ([@B68]; [@B69]). NCL is the method of choice for the generation of longer sequences (\>50 amino acids) out of two or more fragments and was influenced by the work of [@B28] and [@B1]. At the same time, it decreases limitations of SPPS due to synthesizing shorter peptide fragments and fusing them to yield the native peptide sequence after purification and characterization of each fragment. The basic principle behind the NCL is the reaction of a N-terminal cysteine of one peptide fragment with a C-terminal thioester of another peptide fragment in aqueous phosphate buffers, containing 6 M guanidinium HCl or 8 M urea together with a reducing agent like TCEP or DTT ([@B27]). However, the greatest obstacle for the NCL of lipophilic peptides is their insolubility in conventional ligation buffers. Last decades, researchers tried also to bypass the Boc-based SPPS protocol that had to be used for the synthesis of the thioester fragment.

Various strategies have been developed to improve SPPS/NCL protocols and to overcome aggregation and limitations of these methods for "difficult sequences" ([@B104]). These methods can be divided into two main groups: (1) modifications of external conditions and (2) internal modifications of the peptide side chain or backbone ([Figure 3](#F3){ref-type="fig"}). In following detailed strategies for optimization of SPPS and NCL for "difficult sequences" will be discussed.

External Conditions {#S3.SS1}
-------------------

The addition of *organic solvents* is one of the earliest strategies to dissolve hydrophobic peptides. Polar organic solvents like DMF, DMSO, and NMP are known for their increased solvation potential to inhibit peptide aggregation on the resin. A so-called "magic mixture," which is composed of DCM, DMF and NMP (1:1:1) has become famous for the synthesis of hydrophobic peptides and was successfully applied for the synthesis of various "difficult sequences" ([@B131]). Similarly, for the NCL these solvents also found their application as additives to conventional ligation buffers. For example, the NCL of transmembrane peptides such as the rhodopsin II/transducer complex was performed in the presence of DMSO or DMF resulting in 65% yield ([@B30], [@B31]). This strategy was also successfully applied for the ligation of various other hydrophobic proteins, such as small hemithioindigo (HTI)-based chromopeptide ([@B71]), and O-acyl isopeptides ([@B121]).

Another promising approach is the addition of 2,2,2-trifluoroethanol (TFE) or 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) to N,N-dimethylformamide (DMF) during the coupling steps in order to increase the polarity and solvation properties of the solvent. Examples for this strategy represent the synthesis of d-Ala^17^-*phGnRH*(14--36) ([@B91]) or model "difficult sequences" ([@B148]). Fluorinated alcohols are also known as effective solvents for hydrophobic peptides, which can be used during analytics and purification, namely key steps two and three, of the chemical production ([Figure 1](#F1){ref-type="fig"}; [@B130]; [@B14]; [@B156]). The reason for that is that TFE or HFIP mimic the natural environment of the cell membrane thus mediate the dissolution of membrane-associated peptides. Intra-molecular H-bonds can be stabilized through fluorinated alcohols, preserving especially the α-helical structure of the transmembrane region ([@B46]). Fluorinated alcohols such as TFE, HFIP or 1-phenyl-2,2,2-trifluoroethanol (PhTFE) also found their application in NCL as co-solvent. Impressing examples of this approach were published by M. Hong et al. and W. DeGrado et al. who used TFE and HFIP as co-solvents for the NCL during the synthesis of influenza virus A proton channel AM2 ([@B73]; [@B76]) and in our studies for the synthesis of influenza virus B proton channel BM2(1--51) fragment ([@B7]).

*Chaotropic agents* belong to a group of water-soluble ingredients which can disturb hydrogen bonds between water molecules and proteins. Examples for chaotropic agents include various salts, detergents, polar organic solvents or urea and thiourea. Additionally, chaotropic ions such as Li^+^, Mg^2+^, SCN,^--^ and ClO~4~^--^ can be added to reduce non-covalent hydrophobic interactions and consequently prevent precipitation of poor-soluble peptides ([@B28]; [@B158]).

The effect of ions on the stability of secondary and tertiary structures and on the solubility of peptides were intensively studied by multiple groups ([@B28]) and summarized in the Hofmeister series ([@B16]). The use of chaotropic agents is of great importance for NCL reaction with the first reported NCL studies by Kent and co-workers already performed in guanidinium hydrochloride-based buffers ([@B28]). Nowadays, the majority of ligations are executed in aqueous buffers containing high concentrations of chaotropic agents like urea or guanidinium hydrochloride ([@B104]). These two ingredients prevent the formation of unfavorable secondary structures thus enhancing the solubility of peptides. However, ligation of hydrophobic peptides is strongly limited in these standard ligation buffers due to the poor solubility of the peptide/protein fragments.

In contrast to chaotropic agents, *surfactants* are applied to mimic the natural environment of cell membranes. In aqueous solutions surfactants form micelles or lipid liposomes in which hydrophobic transmembrane peptides can easily be incorporated. Several studies demonstrated that transmembrane proteins spontaneously fold while incorporated in an artificial lipid membrane. This behavior is utilized in analytical applications such as circular dichroism (CD) spectroscopy and solution nuclear magnetic resonance (NMR) studies ([@B33]; [@B77]; [@B84]). In order to aid NCL multiple surfactants were investigated to increase the solubility of transmembrane peptides in guanidinium chloride or urea as additives to ligation buffer. Main advantage accompanied using surfactants is their commercial accessibility and fast experimental screening. Examples for frequently used surfactants are 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) ([@B100]), n-octyl glycoside (OG) and dodecylphosphocholine (DPC) ([@B78]). An impressive example for the value of this strategy was made by Becker and co-workers who used n-octyl glycoside (OG) as an additive for the NCL to synthesize transmembrane peptide diacylglycerol kinase (DAGK) comprising 121 amino acids ([@B78]). Other successful examples were reported using SDS for the NCL of the potassium channel KcsA comprising 125 amino acids ([@B137]). Although surfactants are applied as additives for protein and peptide solubilization for many years, several publications indicate that they could interfere with RP-HPLC columns and reduce the signal intensity in mass spectrometry ([@B81]; [@B104]).

During the last decade *ionic liquids* (ILs) gathered much attention as potent reaction and solubilizing media for biomaterials, including hydrophobic peptides and cellulose ([@B125]; [@B90]). Several promising examples were published where ILs, in particular 1-ethyl-3-methylimidazolium acetate (\[C~2~mim\]\[OAc\]) was described as advantageous solvent for oxidative folding of highly hydrophobic cysteine-rich peptides (e.g., conotoxins) or NCL ([@B90]; [@B132]; [@B12]). The \[C~2~mim\]\[OAc\] was used as media for the NCL of the 66-meric tridegin, which is known as an inhibitor of human blood coagulation factor XIIIa ([@B11]). However, N-heterocyclic carbenes (NHC) which are present in the neat \[C~2~mim\]\[OAc\], generated by subtraction of C2 proton by relatively basic acetate anion, initiated formation of a high percentage of by-products and therefore prevented the breakthrough of this method. In 2017, we identified those NHC-induced side-products and studied conditions where the formation of those side-products can be entirely suppressed, therefore enabling using \[C~2~mim\]\[OAc\] as a solvent during NCL ([@B6]). Additionally, [@B142] reported protease-catalyzed ligation in the presence of 60% of 3-methylimidazolium dimethylphosphate in buffer solution with high turnover rates.

Internal Modifications {#S3.SS2}
----------------------

*Temporary internal (structural) modifications* of the peptide sequence have revolutionized the use of the Fmoc-based SPPS protocol on "difficult sequences." Today several different backbone modifications exist mainly focused to prevent side-reaction such as diketopiperazine or aspartimide formation ([@B104]). Many of them offer also the advantage to reduce peptide aggregation on solid support thus facilitate the accessibility of the N-terminus during SPPS ([@B131]). Depending on their structure, most backbone modifications can be classified in ortho-hydroxybenzyl groups \[Hmb ([@B52]), Hmsb ([@B51]), Hbz ([@B62]), Hnb ([@B88])\] ortho-mercaptobenzyl groups \[Dmmb ([@B66]), Tmb ([@B98])\] and methoxybenzyl groups \[Dmb ([@B153]), Mmsb ([@B128])\]. Additionally, several other protection groups were developed which cannot be assigned to one of the aforementioned backbone modifications such as EDOTn ([@B53]), Dcpm ([@B19]), Etom ([@B38]), 2-furfury and 2-thlenylmethyl ([@B64]) groups. In the 1990ies, one of the first backbone amide protection groups, which remarkably improved handling of aggregation-prone peptides, was developed, N,O-bis(Fmoc) derivates of Nα-2-hydroxy-4-methoxybenzylamino acids (Hmb) ([@B154]). This group demonstrated the ability to facilitate synthesis of an acyl carrier protein, a 65--74 decapeptide that showed strong inter-chain association ([@B144]; [@B106]). Thus, the Hmb moiety and its derivates were developed, which were frequently used in Fmoc-based SPPS ([@B120]; [Table 2](#T2){ref-type="table"}).

###### 

Backbone amide protecting groups that can be removed during cleavage.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Structure**                                    **Advantages**                                                                 **Limitations**
  ------------------------------------------------ ------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------
  ![](fbioe-08-00162-i001.jpg)\                    • Inhibition of aspartimide formation\                                         • Poor *O-N*-acyl transfer
  Hmb ([@B63], [@B64]) (Fmoc SPPS)                 • Commercial availability of dipeptides and amino acids containing Hmb group   

  ![](fbioe-08-00162-i002.jpg)\                    • Suppression of aspartimide formation\                                        • Bulkiness\
  Dmb ([@B143]; [@B10]) (Fmoc/Boc SPPS)            • Rapid removal at high concentrations of TFA\                                 • Dipeptides are restricted to Substitution sites containing Ser, Thr and Gly (and in some cases Cys)
                                                   • Commercial availability of dipeptides and amino acids containing Dmb group   

  ![](fbioe-08-00162-i003.jpg)\                    • Commercial availability of Tmob-protected amino acids\                       • Bulkiness
  Tmob ([@B64]) (Fmoc SPPS)                        • Faster acylation compared to Dmb.\                                           
                                                   • High acid lability, can be removed with 5% TFA in DCM                        

  ![](fbioe-08-00162-i004.jpg)\                    • Lower steric hindrance and faster acylation compared to Dmb                  • Bulkiness
  MIM ([@B53]) (Fmoc SPPS)                                                                                                        

  ![](fbioe-08-00162-i005.jpg)\                                                                                                   
  EDOTn ([@B53]) (Fmoc SPPS)                                                                                                      

  ![](fbioe-08-00162-i006.jpg)\                    • Higher acid lability compared to Hmb                                         • Inefficiency of the coupling of the incoming amino acid onto the N-(furfury/thienyl)peptidyl-resin
  2-furfury/2-thienylmethyl ([@B64]) (Fmoc SPPS)                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Further strategies aiming to decrease on-resin aggregation during SPPS include the use of pseudoprolines ([@B95]; [@B146]) or O-acyl isopeptides ([@B47]) (depsipeptides) ([Figure 4](#F4){ref-type="fig"}). Mutter's lab introduced pseudoprolines incorporating them into a sequence with numerous building blocks being commercially available ([@B95]; [@B146]). The cyclic oxazolidine (Ser, Thr) thiazolidine (Cys) ring system shows structural similarities with Pro, resulting in a "kink" conformation within the growing peptide chain preventing aggregation, self-association and a β-sheet formation ([@B147]). An alternative strategy to interrupt unfavorable secondary structures is the synthesis with O-acyl isopeptides which were developed by [@B121]. This strategy relies on the introduction of oxo-esters over Ser or Thr residues within the primary sequence. The strategy was successfully applied for SPPS of several lipophilic peptides ([@B67]).

![Example of pseudoproline **(A)** and isopeptide **(B)** strategies as temporary structural modifications.](fbioe-08-00162-g004){#F4}

Apart from their structure, *backbone modifications* can be classified into two categories: (1) modifications, removable during cleavage from the resin ([Table 2](#T2){ref-type="table"}) and (2) modifications, removable after cleavage from the resin ([Table 3](#T3){ref-type="table"}).

###### 

Backbone amide protecting groups that remain on the sequence after cleavage from solid support and require special conditions to be detached.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Structure**                                                   **Advantages**                                                                               **Limitations**
  --------------------------------------------------------------- -------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------
  ![](fbioe-08-00162-i007.jpg)\                                   • "Safety-catch" protecting group                                                            • Bulkiness
  Hmsb ([@B49]) (Fmoc SPPS)                                                                                                                                    

  ![](fbioe-08-00162-i008.jpg)\                                   • Efficient acylation, suppression of epimerization\                                         • Bulkiness
  1,3-Benzoxathiole-3-oxide derivative ([@B97]) (Fmoc/Boc SPPS)   • "Safety-catch" protecting group                                                            

  ![](fbioe-08-00162-i009.jpg)\                                   • "Safety-catch" protecting group                                                            • Slightly slower coupling of incoming amino acids onto the 4-methoxy-2-Nb-peptidyl-resin compared to Hmb
  4-Methoxy-2-Nb ([@B60]) (Fmoc/Boc SPPS)                                                                                                                      

  ![](fbioe-08-00162-i010.jpg)\                                   • Resistance under acidic conditions and acidic lability after the reduction of sulfoxide\   • Bulkiness
  Mmsb ([@B102]) (Fmoc SPPS)                                      • Prevention of aspartimide and diketopiperazine formation\                                  
                                                                  • Facilitation of cyclization                                                                
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The first group of modifications only facilitates the SPPS by preventing on-resin aggregation of "difficult sequences" ([Table 2](#T2){ref-type="table"}). Although, the second group, includes modifications which are stable during final cleavage from solid support and additionally improves the handling and purification of poor-soluble peptides after cleavage from the solid support ([Table 3](#T3){ref-type="table"}).

Lately, the use of solubilizing units/tails/tags gained great attention. These units are usually made of multiple hydrophilic amino acids that are attached to the hydrophobic sequence and are apparently designed toward facilitating purification *via* HPLC, peptide condensation or NCL. Especially the use of polyarginine and polylysine units is widely represented in literature ([@B161]). *Solubilizing tags* can be attached to the N-terminus, C-terminus or side chain of amino acids in a sequence. *N-terminal tags*, are barely represented in literature and mostly used to increase the solubility of hydrophobic peptides for purification. Examples for N-terminal tags were reported for different model peptides ([@B35]; [@B136]) and for the insulin A chain ([@B29]). *C-terminal tags*, belong to the most applied strategies to increase the solubility of poorly soluble peptides. In [@B34] were the first who tested a C-terminal poly-glycine-arginine tail to increase the solubility of the peptide CP10 (42--55). All these first approaches were mainly used to aid the purification of hydrophobic peptides *via* HPLC. Further examples of similar strategies were published for insulin glargine ([@B48]), NY-ESO-1 ([@B44]) or Q11 ([@B103]). Especially useful is the C-terminal tag strategy in combination with MPA-thioester peptides (3-mercaptopropionic acid, MPA). Thereby, the solubilizing tag can be directly attached at the MPA moiety which is removed during NCL. Successful examples for this method were reported for the ligation of HIV 1 protease ([@B61]), ORL1 (288--370) ([@B112]), DEN2C (21--100) ([@B155]), and many more ([@B122]; [@B150]). However, major disadvantage of MPA-thioester peptides is their compatibility with Boc-based SPPS. A useful alterative to MPA-thioester peptides are Dbz and MeDbz groups which are compatible with Fmoc-based SPPS. This novel approach was used for the ligation of SUMO-2 and ubiquitin (1--93) ([@B13]). In 2018, we introduced another Fmoc-based SPPS compatible C-terminal tag (polylysine, miniPEG) strategy using thioester-forming oxo-esters by introduction of 2-hydroxy-3-mercaptopropionic acid (Hmp) group for the ligation of the proton channel M2 of influenza virus B resulting in almost quantitative ligation yield ([@B7]).

Beneath C-terminal solubilizing tags the second most applied method is the attachment of *side-chain or backbone tags* to hydrophobic peptides. *Side-chain tags*, can be introduced during or after sequence elongation and after the fragment is prepared. A recent publication by [@B134] described a method using trityl-Lys (Trt-K) and trityl-Arg (Trt-R) solubilizing tags that can be inserted directly to the unprotected peptide and thus serves as an aid during NCL. They were able to successfully synthesize Cp149-NH~2~, a Hepatitis B capsid protein out of three fragments. A further recently designed method was presented by [@B15] who introduced a novel arginine-modified acetamidomethyl tag (Acm^R^). Making use of the orthogonal Cys protection group Acm, which remains bound during final cleavage and removed in an additional step using mild reducing conditions. Here, the acetyl group is functionalized by introduction of polyarginine residues. The successful synthesis of a β-subunit of the human thyroid-stimulating hormone highlights the applicability of this method. A further way of utilizing a side chain solubilizing unit coupled to a cysteine moiety was recently presented by the Brick group. They introduced a phenylacetamidomethyl tag (Phacm) containing three arginine units and efficiently synthesized the copper storage protein CSP-1 ([@B56]). Examples of solubilizing tags and even combination of both strategies -- removable backbone modifications and solubilizing tags -- are given in the [Table 4](#T4){ref-type="table"} (reviewed in detail by [@B159]).

###### 

Examples of combinations of removable backbone modifications and solubilizing tags.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Structure**                                           **Features**
  ------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------
  ![](fbioe-08-00162-i011.jpg)\                           • Attached to Gln\
  Nitrobenzene linkage solubilizing tag ([@B50])          • Synthesis of the tag: three steps, 51% yield\
                                                          • Introduced during SPPS\
                                                          • Selective complete removal (365 nm UV)\
                                                          • Cannot be used for synthesis of the esterified proteins

  ![](fbioe-08-00162-i012.jpg)\                           • Attached to Cys\
  Phacm linkage solubilizing tag ([@B82])                 • Synthesis of the tag: four steps, 35% yield\
                                                          • Introduced during SPPS\
                                                          • Selective complete removal (MgCl~2~/PdCl~2~, 6 M Gdn HCl)

  ![](fbioe-08-00162-i013.jpg)\                           • Attached to Cys\
  Acm linkage solubilizing tag ([@B15])                   • Synthesis of the tag: two steps, 28% yield\
                                                          • Introduced during SPPS;\
                                                          • Deprotection under the typical conditions of Acm removal; no additional steps needed

  ![](fbioe-08-00162-i014.jpg)\                           • Attached to Cys\
  Trt-K/R~n~ solubilizing tag ([@B135])                   • Synthesis of the tag: 56% yield\
                                                          • Must be introduced after the cleavage of the fragment from the resin\
                                                          • Low removal efficiency (TFA/TIS, 41%)

  ![](fbioe-08-00162-i015.jpg)\                           • Attached to Asp, Glu, Asn, Gln\
  Dbz-Trt-K~n~ solubilizing tag ([@B133])                 • Synthesis of the tag: four steps, 78% yield\
                                                          • Must be attached after the fragment is prepared\
                                                          • Removal: NaNO~2~, then hydrolysis or ammonolysis

  ![](fbioe-08-00162-i016.jpg)\                           • Attached to Lys\
  Ddae linkage solubilizing tag "helping hand" ([@B54])   • Synthesis of the tag: one step, 67% yield\
                                                          • Introduced during SPPS\
                                                          • Can be directly removed after NCL or desulfurization (1 M hydrazine)

  ![](fbioe-08-00162-i017.jpg)\                           • Attached to Lys\
  Can linkage solubilizing tag ([@B136])                  • Synthesis of the tag: five steps, 21% yield\
                                                          • Introduced during SPPS\
                                                          • Hydrazide method of peptide thioesters preparation cannot be applied if Can-tag is used since the Can residue may react with NaNO~2~\
                                                          • Desulfurization of Can-containing peptide is challenging\
                                                          • Removal 1 M NH~4~OAc (pH 4.5)

  ![](fbioe-08-00162-i018.jpg)\                           • Attached to backbone of the different amino acids\
  Backbone Hmb linkage solubilizing tag ([@B161])         • Synthesis of the tag: one step, 76% yield\
                                                          • Despite of bulkiness, efficient incorporation into the various amino acid sites (Phe-Ile, Ile-Leu, Cys-Ile, Lys-Leu)\
                                                          • Inefficient incorporation into the high steric hindered sites (Val-Ile)\
                                                          • Prevents aggregation of the peptide\
                                                          • removal: TFA

  ![](fbioe-08-00162-i019.jpg)\                           • Attached to C-terminus\
  Hmp ADO, Hmp ADO~2~ or Hmp ADO-Lys~5~ ([@B7])           • Synthesis of Hmp group: two steps, 67% yield\
                                                          • Convenient attachment during SPPS\
                                                          • Hmp is unstable in piperidine 2-methyl-piperidine must be used instead\
                                                          • The tag is removed during NCL

  ![](fbioe-08-00162-i020.jpg)\                           • Attached to C-terminus\
  Thioester linkage solubilizing tag ([@B112])            • No need to prepare a linkage in advance\
                                                          • Facile introduction during SPPS\
                                                          • Removal of the tag *in situ* during NCL\
                                                          • Suitable for Boc-based SPPS only\
                                                          • Cannot be applied for the synthesis of acid-sensitive post-translational modifications\
                                                          • The tag is automatically removed during NCL

  ![](fbioe-08-00162-i021.jpg)\                           • Attached to C-terminus\
  HMBA linkage solubilizing tag ([@B43])                  • Suitable for Boc- and Fmoc-based SPPS\
                                                          • Easy efficient synthesis of the linker\
                                                          • The tag is removed during NCL
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Follow-Up Protocols {#S3.SS3}
-------------------

Synthesis and NCL of highly hydrophobic peptides and proteins is usually not straight-forward and requires several tools. The earlier presented solubilizing units are only one factor of several to facilitate the complete synthesis. In the following, methods will be presented that provide either the appropriate ligation side or to mask native cysteines within the sequence that are not used as ligation sites. Cysteines are not highly abundant within sequences of highly hydrophobic peptides/proteins, such as membrane proteins, necessitating incorporation of a reversable mutation within the peptide sequence. Furthermore, sequences of \> 50 amino acids often need to be divided into two or more fragments. This approach though, requires masked ligation sites to enable the second or third ligation.

The classical NCL by Kent and colleges can only be performed if Cys-residue is located at the ligation site. Unfortunately, the Cys is underrepresented in most native peptide sequences with an occurrence of only 2.26% in mammals ([@B92]). To circumvent this issue of not having a Cys-residue within the sequence or at the desired ligation site, other amino acids must be found that can replace a cysteine residue and readily converted in the natural occurring moiety. The mild desulfurization of Cys to Ala residues, which are much more frequently represented in native sequences, expanded the limitations of the NCL ([@B105]). Further, the Payne lab and other groups introduced new proteinogenic amino acids aside from Ala, utilizing Asn ([@B113]), Asp ([@B129]), and Glu ([@B20]) at a ligation site. [@B17] introduced another way of circumventing the cysteine moiety by auxiliarated NCL introduced with the N^α^ -(ethanethiol) and N^α^ -(oxyethanethiol)-peptide. In [@B80] applied this protocol for cleavage of 2-mercaptoethyl auxiliary group. A recently introduced NCL approach, the diselenide-selenoester ligation (DSL) opens up possibilities for using further amino acids and will be elucidated in the outlook.

The earliest reports about peptide desulfurization include metal-related catalysts such as Raney nickel or palladium/aluminum oxide ([@B149]). However, the usage of these metals have had some drawbacks regarding the yield, epimerization and the incompatibly with the cysteine masking group L-thiazolidine-4-carboxylic acid (Thz). That is why this method was developed further by Wan and Danishefsky, who introduced the metal-free desulfurization using TCEP and VA-044 (2,2′-azobis(2-(2-imidazoline-2-yl)propane)dihydrochloride) ([@B141]). This widely applied method is usually performed in aqueous 6 M guanidinium hydrochloride buffer which can also be used for NCL. Nowadays, this metal-free approach is the most widely used method for NCL-desulfurization protocol and was successfully applied for multiple peptides ([@B59]). However, despite all advantages, poor soluble peptides remain an issue due to their insolubility in conventional buffer systems. For a complete desulfurization, hydrophobic peptides need to be entirely dissolved in the buffer solution. Comparable to NCL, internal and external conditions exist to circumvent solubility problems during desulfurization. Examples for internal strategies were published by [@B135] using a side-chain polylysine tag to increase the solubility during desulfurization. Other examples include the addition of a polyarginine tag at the side chain of amyloid-beta (Aβ) peptides ([@B162]) or polylysine tags over a Ddae-linker for the synthesis of the 97-residue co-chaperonin GroES ([@B41]). External conditions are usually based on the addition of co-solvents such as fluorinated alcohols to the desulfurization buffer. In 2018 we reported the use of HFIP as ideal co-solvent for desulfurization of \[Cys^22^\]BM2(1--51) with a yield of 99% ([@B7]). A further promising approach offers ionic liquids as possible media for peptide desulfurization. Studies performed in \[C~2~mim\]\[OAc\] gave first evidence that Cys can be desulfurized to Ala within the sequence of unprotected peptides ([@B6]).

When applying desulfurization conditions, all other present cysteines need to be orthogonally protected. For that, the most common protection group is the acetamidomethyl (Acm) group proposed in 1971 and is applicable to both Boc- and Fmoc-based SPPS ([@B138]; [@B139]). To retain the native sequence, cleavage of the Acm-group needs to be performed. [Table 5](#T5){ref-type="table"} gives an overview of the various, diversified methods to remove the Acm-group, with many methods also aiming for the generation of distinct disulfide-bridges within peptide sequences. Therefore, the mentioned in [Table 5](#T5){ref-type="table"} methods can be applied for "difficult sequences."

###### 

Various protocols for the removal of the Acm protection group.

  **No.**   **Acm-group removal conditions**                                                                            **Peptide synthesized**                                          **Product**            **References**
  --------- ----------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------- ----------------
  1         Silver trifluoromethansulfonate (AgOTf) in presence of anisole/precipitated in ether and treated with DTT   Oxytocin, chicken calcitonin                                     Free thiol             [@B40]
            AgOTf followed by DMSO/aqueous HCl treatment                                                                Tachyplesin I, endothelin I                                                             [@B126]
            (AgOTf)/HCl DTT                                                                                             Gstl protein                                                                            [@B110]
  2         DMSO-TFA oxidation in presence of free sulfhydryl groups                                                    Oxytocin, human calcitonin gene-related peptide                  Disulfide              [@B74]
  3         Thallium trifluoroacetate, (CF3COO)3Tl in TFA                                                               Oxytocin, human calcitonin gene-related peptide, urothensin II   Disulfide              [@B39]
  4         Iodine/acetic acid in HOAc, HCl                                                                             Human insulin-like peptide 3 analogous                           Disulfide              [@B157]
  5         Triisopropylsilane in TFA (2/98)                                                                            Model peptides                                                   Disulfide/free thiol   [@B124]
  6         Palladium, Pd(II) complex                                                                                   Ubiquitin-like protein, UBL-5                                    Free thiol             [@B83]

Another, so-called "masking" group for cysteine is Thz-group, mentioned earlier in this section. When NCL must be performed in multiple steps, the Thz group helps to reversibly protect N-terminal cysteine. This group can be cleaved afterward using methoxyamine⋅HCl at pH 4 ([@B94]). An additional benefit of the Thz conversion is the suitability to perform the transformation within the ligation buffer following a one-pot approach ([@B5]; [@B37]). Therefore, to use Thz in the chemical synthesis strategy followed by NCL ligation conditions must be optimized and described above. Targeting a faster unmasking reaction (usually 8 h with methoxyamine), the Brik lab introduced an extremely fast (15 min) palladium-based Thz conversion presenting efficient synthesis of Lys34-ubiquitinated histone protein, H2B ([@B57]).

Additionally, another interesting approach was currently employed to synthesize the H2B protein ([@B58]). The solid phase chemical ligation (SPCL) makes on-resin NCL possible and, with respect to desulfurization, is advantageous because reactants that would interfere and decrease the efficiency are washed off, e.g., MPAA.

Hot Topics and Outlook {#S4}
======================

The great potential and importance of membrane proteins in elucidation of their structures and function as well as development of novel drug leads targeting membrane proteins causes research in this area to flourish. Moreover, need in being able to incorporate post-translational modifications, isotopic labels or peptide-mimetics rely on robust approaches of chemical synthesis ([@B160]).

[@B114] recently summarized the possibilities of ligases to perform amide bond formation during ligation reactions in a review opening a platform for biological engineering. In a very recent review, [@B96] discuss advantages and disadvantages of enzymes used for ligation and cyclization suggesting a sortase-mediated ligation strategy to be straightforward. They also elucidate the possibility to use enzymes for cyclization and labeling, showing the versatile applications of engineered and naturally occurring enzymes.

With great interest to solve solubility problems during NCL, but also handling of peptides, ionic liquids seem to have enormous potential ([@B132]; [@B6]). Besides SPPS and NCL, purification of these "difficult sequences" is not trivial. Apart from the usage of the already mentioned alternative organic solvents application at RP-HPLC to purify fragments and products, just recently an alternative approach has been introduced by using catch-and-release purification method which is based on base-labile cleavable linkers using oxime-based and hydrazine-based ligation chemistry ([@B107]).

Recently, a new and rapid ligation method was presented: the additive-free diselenide-selenoester ligation (DSL) ([@B93]). Making use of a peptide selenoester and a peptide diselenide bearing an N-terminal (Sec)~2~ unit, the thiol-free ligation was completed within minutes. Giving an example of the time-saving advantage this method provides, Mitchell et al. were able to completely synthesize an early secretory antigenic protein-6 (ESAT-6) within only 16 h including a deselenization of the Sec unit to Ala ([@B93]). The deselenization reaction is further employable to other amino acids, such as aspartate and glutamate auxiliaries ([@B24]) and is even employable to poorly soluble compounds. This is demonstrated by synthesis of the poorly soluble therapeutic lipopeptide tesamorelin and variants of the transmembrane lipoprotein phospholemman FXYD1 using this method and nanomolar concentrations circumventing the integration of solubilizing units ([@B22]). Broadening the ligation toolkit, the α-ketoacid-hydroxylamine (KAHA) ligation route is also employable to poorly soluble and highly hydrophobic proteins such as IFITM3 (see [Table 1](#T1){ref-type="table"}) or the antibacterial cyclic AS-48 protein ([@B108]) making use of 5-oxaproline within acidic conditions. The KAHA ligation is applicable to synthesized fragments from Fmoc-synthesis, integrated solubilizing tags and based on ligation conditions in organic solvents and thus presents an alternative to fragments facing solubility problems.

All presented methods and protocols are based on traditional "batch" chemistry but a novel approach toward continuous-flow peptides synthesis ([@B89]) or ligation and desulfurization ([@B21]). They presented an in-line flow-based ligation and desulfurization protocol and presented synthesis of enfuvirtide (HIV drug) and the diagnostic agent somatorelin. This procedure could be interesting in the future especially considering scale-up of ligation reactions.

Having given an overview of synthetic strategies and follow- up protocols available to date, it is obvious that there is no one-fits-all approach. Membrane proteins are of great interest and thus robust synthesis routes will help to investigate structural behavior leading to a better understanding of the diagnostic points of action and possibilities. Limitations in a straight-forward design are the extreme hydrophobic regions within the protein sequences that lead to aggregation on resin making synthesis challenging. Overcoming this limitation, NCL enables segmentation of the sequence into two or more fragments that can be successively condensed. Especially transmembrane regions are challenging to be synthesized even out of smaller fragments, incorporation of removable solubilizing tags represent a method to facilitate handling, synthesis and purification. However, the general protocols and a variety of choice can be used in order to meet a right choice for the synthesis of any particular "difficult sequences" especially membrane proteins of functional parts of them ([Figure 3](#F3){ref-type="fig"}).
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